Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 12, 2013, Pages 2683-2696

  Itagaki, Hiroko ^a   Shimizu, Kazuhiko ^a   Morikawa, Shunichi ^a   Ogawa, Kenji ^b   Ezaki, Taichi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

CD68 antigen; Kupffer cells; Liver fibrosis; Matrix metalloproteinase (MMP); Mouse; Non alcoholic fatty liver disease (NAFLD)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CCL2 PROTEIN, MOUSE; CD68 ANTIGEN; CD68 PROTEIN, MOUSE; COLLAGENASE 3; CYCLINE; DIFFERENTIATION ANTIGEN; GELATINASE B; LEUKOCYTE ANTIGEN; MESSENGER RNA; METHIONINE; MMP13 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CELL PROLIFERATION; DISEASE MODEL; FATTY LIVER; GENE EXPRESSION REGULATION; GENETICS; KUPFFER CELL; LIVER; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MATRIX METALLOPROTEINASE (MMP); METABOLISM; MOUSE; NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD); NONALCOHOLIC FATTY LIVER; PATHOLOGY; TIME; ULTRASTRUCTURE; VITAMIN DEFICIENCY;

CD68 ANTIGEN; KUPFFER CELLS; LIVER FIBROSIS; MATRIX METALLOPROTEINASE (MMP); MOUSE; NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD);

ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CELL PROLIFERATION; CHEMOKINE CCL2; CHOLINE DEFICIENCY; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE EXPRESSION REGULATION; KUPFFER CELLS; LIVER; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; METHIONINE; MICE; MICE, INBRED C57BL; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, MESSENGER; TIME FACTORS;

EID: 84888795580     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sanyal AJ. NASH: A global health problem. Hepatol Res 2011; 41: 670-674.
2. Krawczyk M, Bonfrate L and Portincasa P. Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2010; 24: 695-708.
3. Mu YP, Ogawa T and Kawada N. Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-choline-deficient diet. Lab Invest 2010; 90: 245-256.
4. Lefkowitch JH, Haythe JH and Regent N. Kupffer cell aggregation and perivenular distribution in steatohepatitis. Mod Pathol 2002; 15: 699-704.
5. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 2009; 51: 212-223.
6. Maina V, Sutti S, Locatelli I, Vidali M, Mombello C, Bozzola C and Albano E. Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice. Clin Sci (Lond) 2012; 122: 545-553.
7. Oz HS, Chen TS and Neuman M. Methionine deficiency and hepatic injury in a dietary steatohepatitis model. Dig Dis Sci 2008; 53: 767-776.
8. Kawashima T. Oil red O stain. Medical Technology. Tokyo: ISHIYAKU Publishers, Inc., 1999; pp: 45-46.
9. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
10. Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA; NASH Clinical Research Network (CRN). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011; 53: 810-820.
11. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
12. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M and Farrell GC. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 2004; 40: 386-393.
13. Anstee QM and Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006; 87: 1-16.
14. Tsujimoto T, Kawaratani H, Kitazawa T, Hirai T, Ohishi H, Kitade M, Yoshiji H, Uemura M and Fukui H. Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model. World J Gastroenterol 2008; 14: 6036-6043.
15. Khosravi S, Alavian SM, Zare A, Daryani NE, Fereshtehnejad SM, Keramati MR, Abdollahzade S and Taba Taba Vakili S. Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings. Hepat Mon 2011; 11: 452-458.
16. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C and Tacke F. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009; 50: 261-274.
17. Diehl AM. Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 2002; 282: G1-5.
18. Armbrust TS, Chitnis PR and Guikema JA. Organization of photosystem I polypeptides examined by chemical cross-linking. Plant Physiol 1996; 111: 1307-1312.
19. Park JW, Jeong G, Kim SJ, Kim MK and Park SM. Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients. J Gastroenterol Hepatol 2007; 22: 491-497.
20. Zhao J, Zhou G, Li M, Li W, Lü J, Xiong L, Liang L, Zhao Y, Xu D and Yu J. A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis. Scand J Gastroenterol 2010; 45: 1360-1371.
21. Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, Huss S, Klussmann S, Eulberg D, Luedde T, Trautwein C and Tacke F. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 2012; 61: 416-426.
22. Sakaida I, Hironaka K, Terai S and Okita K. Gadolinium chloride reverses dimethylnitrosamine (DMN)-induced rat liver fibrosis with increased matrix metalloproteinases (MMPs) of Kupffer cells. Life Sci 2003; 72: 943-959.
23. Hironaka K, Sakaida I, Matsumura Y, Kaino S, Miyamoto K and Okita K. Enhanced interstitial collagenase (matrix metalloproteinase-13) pr-
24. Uchinami H, Seki E, Brenner DA and D'Armiento J. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 2006; 44: 420-429.